Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
142047-97-0
17640-26-5
17639-73-5
110-99-6
120289-22-7
817-95-8
887247-28-1 | methyl 3-amino-5-(pyridin-3-yl)thiophene-2-carboxylate | AA00H45F | MFCD11207975
92288-70-5 | 2-(4-(2-oxooxazolidin-3-yl)phenyl)acetic acid | AA00H53X | MFCD11167845
945-43-7 | 6,7-Dimethyl-5,6,7,8-tetrahydropterin hydrochloride | AA00H5XO | MFCD00012731
95-76-1 | 3,4-Dichloroaniline | AA00H7IG | MFCD00007768
956229-69-9 | 2-(tert-Butoxycarbonyl)phenylboronic acid pinacol ester | AA00H8O6 | MFCD03453053
1008582-71-5 | 4-carbamoyl-2-[3-(trifluoromethyl)benzenesulfonamido]butanoic acid | AA00H9A4 | MFCD05267034
1018450-07-1 | 3-Iodo-5-methylcinnamonitrile | AA00H9KF | MFCD21496416
1031927-20-4 | 1-(3-Chloro-4-methylphenyl)imidazolidin-2-one | AA00H9WX | MFCD09998747
104115-70-0 | Ethyl 4,7-dichloro-1h-indole-2-carboxylate | AA00HA7J | MFCD04966955
1051393-66-8 | (1R,2S,5S)-Rel-3-[(tert-butoxy)carbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid | AA00HAII | MFCD02682400